E Salminen1, K E Clemens, K Syrjänen, H Salmenoja. 1. Department of Oncology and Radiotherapy, Turku University Hospital, P.O. Box 52, Savitehtaankatu 1, Turku, Finland. eeva.salminen@tyks.fi
Abstract
BACKGROUND: To clarify the prevalence and severity of the symptoms, 203 consecutive patients with breast, prostate and other cancers treated mainly for palliation were surveyed. MATERIALS AND METHODS: The series includes 116 men and 87 women with the mean age of 65 years (range 27-86 years). The patients filled-up the Edmonton Symptom Assessment System (ESAS) questionnaire with 11 items describing cancer-related symptoms in the visual analogue scale (VAS). RESULTS: Altogether, 98% of the patients reported at least 1 of the 10 symptoms. There was a significant difference in the score frequencies between the 10 symptoms (p = 0.0001), fatigue receiving the highest frequency (50.8%) of the high scores. Fatigue was also the single most frequent symptom reported by 86.3% of the patients, followed by pain at effort (71.5%), sleeplessness (71.1%) and depression (59.0%). The most disturbing syndrome was pain (n = 48, 23.9%), followed by fatigue (n = 28, 13.9%), depression (9.5%) and dyspnoea (6.0%). Altogether, 75% had more than 5 symptoms and 10% reported all 10 symptoms. The total number of symptoms was not significantly associated with sex (p = 0.781) or age (p = 0.062), but it was associated with the diagnostic group; patients with breast cancer (n = 41) and those with prostate cancer (n = 44) reported fewer symptoms than the patients with other cancers (n = 116)(p = 0.023, Kruskal-Wallis). CONCLUSIONS: Symptoms related to cancer are common among patients treated with palliative indication, but if not specifically surveyed, may remain un-detected and un-treated. ESAS as a clinical tool brings more symptoms to the attention of the physicians and helps in getting a comprehensive insight into the patient's problems.
BACKGROUND: To clarify the prevalence and severity of the symptoms, 203 consecutive patients with breast, prostate and other cancers treated mainly for palliation were surveyed. MATERIALS AND METHODS: The series includes 116 men and 87 women with the mean age of 65 years (range 27-86 years). The patients filled-up the Edmonton Symptom Assessment System (ESAS) questionnaire with 11 items describing cancer-related symptoms in the visual analogue scale (VAS). RESULTS: Altogether, 98% of the patients reported at least 1 of the 10 symptoms. There was a significant difference in the score frequencies between the 10 symptoms (p = 0.0001), fatigue receiving the highest frequency (50.8%) of the high scores. Fatigue was also the single most frequent symptom reported by 86.3% of the patients, followed by pain at effort (71.5%), sleeplessness (71.1%) and depression (59.0%). The most disturbing syndrome was pain (n = 48, 23.9%), followed by fatigue (n = 28, 13.9%), depression (9.5%) and dyspnoea (6.0%). Altogether, 75% had more than 5 symptoms and 10% reported all 10 symptoms. The total number of symptoms was not significantly associated with sex (p = 0.781) or age (p = 0.062), but it was associated with the diagnostic group; patients with breast cancer (n = 41) and those with prostate cancer (n = 44) reported fewer symptoms than the patients with other cancers (n = 116)(p = 0.023, Kruskal-Wallis). CONCLUSIONS: Symptoms related to cancer are common among patients treated with palliative indication, but if not specifically surveyed, may remain un-detected and un-treated. ESAS as a clinical tool brings more symptoms to the attention of the physicians and helps in getting a comprehensive insight into the patient's problems.
Authors: Ernesto Vignaroli; Ellen A Pace; Jie Willey; J Lynn Palmer; Tao Zhang; Eduardo Bruera Journal: J Palliat Med Date: 2006-04 Impact factor: 2.947
Authors: Kathi H Mooney; Susan L Beck; Robert H Friedman; Ramesh Farzanfar; Bob Wong Journal: Support Care Cancer Date: 2014-04-01 Impact factor: 3.603
Authors: Filomena Narducci; Roberta Grande; Lucia Mentuccia; Tiziana Trapasso; Isabella Sperduti; Emanuela Magnolfi; Anna Maria Fariello; Donatello Gemma; Teresa Gamucci Journal: Support Care Cancer Date: 2011-06-19 Impact factor: 3.603
Authors: Lisa K Sprod; Supriya G Mohile; Wendy Demark-Wahnefried; Michelle C Janelsins; Luke J Peppone; Gary R Morrow; Raymond Lord; Howard Gross; Karen M Mustian Journal: J Geriatr Oncol Date: 2012-01-27 Impact factor: 3.599
Authors: Frederieke H van der Baan; Josephine J Koldenhof; Ellen J de Nijs; Michael A Echteld; Danielle Zweers; Ginette M Hesselmann; Sigrid C Vervoort; Jan B Vos; Everlien de Graaf; Petronella O Witteveen; Karijn P Suijkerbuijk; Alexander de Graeff; Saskia C Teunissen Journal: Cancer Med Date: 2020-07-09 Impact factor: 4.452
Authors: Evan Tang; Sumaya Dano; Nathaniel Edwards; Sara Macanovic; Heather Ford; Susan Bartlett; Doris Howell; Madeline Li; Marta Novak; Istvan Mucsi Journal: Qual Life Res Date: 2021-06-17 Impact factor: 4.147